Related references
Note: Only part of the references are listed.Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
Giuseppe Pantaleo et al.
LANCET HIV (2019)
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
Karen V. Kibler et al.
JOURNAL OF VIROLOGY (2019)
HIV/AIDS Vaccines: 2018
Harriet L. Robinson
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector
Maryann Giel-Moloney et al.
VACCINE (2017)
Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets
Maryann Giel-Moloney et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day
Natalie D. Collins et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Novel Concepts for HIV Vaccine Vector Design
Quazim A. Alayo et al.
MSPHERE (2017)
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens
Benedikt Asbach et al.
JOURNAL OF VIROLOGY (2016)
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa
Carlo Zambonelli et al.
PLOS ONE (2016)
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2015)
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
Timothy R. Fouts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Dan H. Barouch et al.
SCIENCE (2015)
Virological and Immunological Characterization of Novel NYVAC-Based HIV/AIDS Vaccine Candidates Expressing Clade C Trimeric Soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as Virus-Like Particles
Beatriz Perdiguero et al.
JOURNAL OF VIROLOGY (2015)
Mixture models for single-cell assays with applications to vaccine studies
Greg Finak et al.
BIOSTATISTICS (2014)
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
Pierre-Alexandre Bart et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials
Anna Sambor et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
Justin Pollara et al.
JOURNAL OF VIROLOGY (2014)
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
Mario Roederer et al.
NATURE (2014)
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
Susan Zolla-Pazner et al.
PLOS ONE (2014)
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
George K. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression
Selena Vigano et al.
PLOS PATHOGENS (2014)
Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
Eduardo Gotuzzo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Dan H. Barouch et al.
CELL (2013)
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
Raphael Gottardo et al.
PLOS ONE (2013)
Single-dose vaccine against tick-borne encephalitis
Alexander A. Rumyantsev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
High-Throughput Quantitative Analysis of HIV-1 and SIV-Specific ADCC-Mediating Antibody Responses
Justin Pollara et al.
CYTOMETRY PART A (2011)
Improved NYVAC-Based Vaccine Vectors
Karen V. Kibler et al.
PLOS ONE (2011)
Characterization of the RepliVax platform for replication-defective flavivirus vaccines
Alexander A. Rumyantsev et al.
VACCINE (2011)
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Michael S. Seaman et al.
JOURNAL OF VIROLOGY (2010)
Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
Juan Garcia-Arriaza et al.
PLOS ONE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Elucidating and Minimizing the Loss by Recombinant Vaccinia Virus of Human Immunodeficiency Virus Gene Expression Resulting from Spontaneous Mutations and Positive Selection
Linda S. Wyatt et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system
Douglas G. Widman et al.
VACCINE (2008)
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA
Linda S. Wyatt et al.
VIROLOGY (2008)
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa
Ming Li et al.
JOURNAL OF VIROLOGY (2006)
Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion
Melanie A. Samuel et al.
JOURNAL OF VIROLOGY (2006)
Production and characterization of vaccines based on flaviviruses defective in replication
Peter W. Mason et al.
VIROLOGY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Detecting differential gene expression with a semiparametric hierarchical mixture method
MA Newton et al.
BIOSTATISTICS (2004)
Mouse neurotoxicity test for vaccinia-based smallpox vaccines
ZQ Li et al.
VACCINE (2004)
Share Paper
